Kepler Cheuvreux Suisse SA Has $32.67 Million Stock Position in Cardinal Health, Inc. $CAH

Kepler Cheuvreux Suisse SA decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 32.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 154,647 shares of the company’s stock after selling 72,928 shares during the quarter. Cardinal Health accounts for about 2.2% of Kepler Cheuvreux Suisse SA’s portfolio, making the stock its 11th largest holding. Kepler Cheuvreux Suisse SA owned approximately 0.07% of Cardinal Health worth $32,675,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Cardinal Health by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after acquiring an additional 617,775 shares during the period. State Street Corp increased its position in shares of Cardinal Health by 1.8% in the fourth quarter. State Street Corp now owns 12,509,230 shares of the company’s stock worth $2,570,647,000 after purchasing an additional 221,497 shares during the period. Geode Capital Management LLC raised its stake in Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Wellington Management Group LLP lifted its position in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after purchasing an additional 3,511,579 shares during the period. Finally, Norges Bank acquired a new stake in Cardinal Health during the fourth quarter worth about $790,344,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on CAH shares. Evercore dropped their target price on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Citigroup reissued a “buy” rating on shares of Cardinal Health in a report on Thursday. Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Finally, Morgan Stanley raised their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $247.80.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $238.79 on Friday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $240.93. The firm has a market capitalization of $55.93 billion, a P/E ratio of 36.51, a P/E/G ratio of 1.17 and a beta of 0.49. The company’s 50 day moving average price is $208.99 and its two-hundred day moving average price is $211.70.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same period last year, the company earned $2.35 earnings per share. The business’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.